C282Y Mutation and Hepatic Iron Status in Hepatitis C and Cryptogenic Cirrhosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increased iron deposition in liver is seen in both primary and secondary hemochromatosis. However, it is not uncommon to see significant iron deposition in a liver biopsy, explant, or autopsy specimen without any significant clinical risk factor. Because of the discovery of the candidate gene (HFE) for hereditary hemochromatosis, we may now be able to screen high-risk patient populations for the abnormal mutation (C282Y). MATERIALS AND METHODS: In this study we analyzed the livers of 50 transplant patients with a diagnosis of either hepatitis C cirrhosis or cryptogenic cirrhosis for the prevalence of the more common C282Y mutation of the HFE gene and correlated the findings to hepatic iron concentration. RESULTS: Of the 26 cases of hepatitis C cirrhosis, 3 were found to be heterozygous for the C282Y mutation. Of the 22 cases of cryptogenic cirrhosis, 1 was found to be heterozygous for the C282Y mutation. Stainable iron was increased in hepatitis C cirrhosis (76.9%) as compared to cryptogenic cirrhosis (50%) (P =. 05). Of the 3 heterozygotes with hepatitis C cirrhosis, 2 showed hepatic iron concentrations of 3+ and 4+, and 1 showed 1+. CONCLUSIONS: We conclude that patients with hepatitis C have an increased tendency to accumulate iron in the liver, and mutations in the HFE gene play a minor role in hepatic accumulation of iron in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HCV infection suppresses hepcidin expression, contributing to iron overload”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [86]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
Edwards, C. Q., Griffen, L. M., Goldgar, D., Drummond, C., Skolnick, M. H., & Kushner, J. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182103 · Cited by 628
Hepatic pathology in relatives of patients with hæmochromatosis
Scheuer, P. J., Williams, R., & Muir, A. R. (1962) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700840107 · Cited by 431
Jazwinska, E. C., Cullen, L. M., Busfield, F., Pyper, W. R., Webb, S. I., Powell, L. W., Morris, C. P., & Walsh, T. P. (1996) · Nature Genetics · doi:10.1038/ng1196-249 · Cited by 419
Measurements of iron status in patients with chronic hepatitis
Di Bisceglie, A. M., Axiotis, C. A., Hoofnagle, J. H., & Bacon, B. R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90339-z · Cited by 391
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
Farinati, F., Cardin, R., De Maria, N., Della Libera, G., Marafin, C., Lecis, E., Burra, P., Floreani, A., Cecchetto, A., & Naccarato, R. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80108-1 · Cited by 377
Iron and Chronic Viral Hepatitis
Bonkovsky, H. L., Banner, B. F., & Rothman, A. L. (1997) · Hepatology · doi:10.1002/hep.510250345 · Cited by 335
Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
Roberts, A. G., Whatley, S. D., Morgan, R. R., Worwood, M., & Elder, G. H. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09436-6 · Cited by 316
SEEBURG, P. H. (1982) · DNA · doi:10.1089/dna.1.1982.1.239 · Cited by 298
Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening
Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., Barton, J. C., Beutler, E., Brittenham, G., Buchanan, A., et al. (1998) · JAMA · doi:10.1001/jama.280.2.172 · Cited by 276
Cited by
Hepcidin and Host Defense against Infectious Diseases
Michels, K., Nemeth, E., Ganz, T., & Mehrad, B. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004998 · Cited by 205
Host genetic determinants in hepatitis C virus infection
Yee, L. J. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364090 · Cited by 121
Diwakaran, H. H., Befeler, A. S., Britton, R. S., Brunt, E. M., & Bacon, B. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00018-1 · Cited by 85
The Role of Iron in the Pathophysiology and Treatment of Chronic Hepatitis C
Price, L., & Kowdley, K. V. (2009) · Canadian Journal of Gastroenterology · doi:10.1155/2009/290383 · Cited by 65
The effect of iron depletion on chronic hepatitis C virus infection
Franchini, M., Targher, G., Capra, F., Montagnana, M., & Lippi, G. (2008) · Hepatology International · doi:10.1007/s12072-008-9076-z · Cited by 58
Metadata
- Authors
- Lal, P., Fernandes, H., Koneru, B., Albanese, E., & Hameed, M.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2000-11
- Volume
- 124
- Issue
- 11
- Pages
- 1632-1635
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W1963040615
- Cited by
- 14
- References
- 32
- Citations by year
- 2015: 1
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Pathology & Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- C282Y mutation, HFE gene, hereditary hemochromatosis, hepatic iron deposition, hepatitis C cirrhosis, cryptogenic cirrhosis, liver transplantation, hepatic iron concentration, iron overload
- MeSH terms
- DNA, Electrophoresis, Agar Gel, Hepatitis C, Humans, Iron, Liver, Liver Cirrhosis, Mutation, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C282Y Mutation and Hepatic Iron Status in Hepatitis C and Cryptogenic Cirrhosis. https://app.cochat.ai/papers/10.5858/2000-124-1632-cmahis
- The paper
- Lal, P., Fernandes, H., Koneru, B., Albanese, E., & Hameed, M. (2000). C282Y Mutation and Hepatic Iron Status in Hepatitis C and Cryptogenic Cirrhosis. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/2000-124-1632-cmahis
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.